Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA - Wikidata - awgldk - TriplyDB

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

http://www.wikidata.org/entity/Q24646731

about

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo A central function for perlecan in skeletal muscle and cardiovascular development Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan Fibroblast growth factor-binding protein is a novel partner for perlecan protein core The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7 Spatial and temporal expression of perlecan in the early chick embryo Developmental expression of perlecan during murine embryogenesis Transcriptional silencing of perlecan gene expression by interferon-gamma Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts.Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism.A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth.The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts.The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Endorepellin evokes autophagy in endothelial cells Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena Heparan sulfate proteoglycans and cancer.Brain-metastatic melanoma: a neurotrophic perspective.Perlecan and tumor angiogenesis.Brain metastases in melanoma: roles of neurotrophins.The role of heparan sulfate and perlecan in bone-regenerative procedures.Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear fact Proteomic profiling of endorepellin angiostatic activity on human endothelial cells Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.Novel interactions of perlecan: unraveling perlecan's role in angiogenesis.The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.The role of the biochemical and biophysical environment in chondrogenic stem cell differentiation assays and cartilage tissue engineering.Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling.Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity.

P2860

Q21710680-B9986676-42EC-4225-892E-8A83ADE398E6 Q24303934-18D392EA-604A-4539-BD81-DC0AE674EA74 Q24312922-A08455BE-468C-4AB3-94E7-309D3039B57F Q24564477-E64176DD-9B8C-44DB-AAEE-D1484A7EC030 Q24648227-270F93B6-D20E-44BF-B602-8181478111B1 Q24653433-FC2CD77D-2D11-4F9E-9AB8-049E2413F593 Q26800258-2B97427C-9126-41D4-B7AA-3D280331FD5A Q28140820-E5AF0B48-3EA3-426D-93B4-41143192A4F9 Q28142123-D2ADC9DB-883C-4CE6-A041-A6AE3D22D66E Q28145823-7708D8A8-1080-4466-86AD-3B949B43D006 Q28245112-A18D26D8-ABB2-4EE8-9DB3-D1366DB4471F Q28251854-97D21C9F-7F65-4F7F-B037-44146DCC70A8 Q28262244-C2FB7FC6-B28E-4562-A568-C7A111BF4204 Q30850721-E09B7D3D-E61D-4616-B6CD-DB9E24D62502 Q31971336-E68E022C-CD73-483A-ACD1-2A1A0B7EF5AE Q33292070-8817FDA9-B3F4-4AF9-9FAC-65184746DA6D Q33304884-E8A87CB6-F9FB-4083-B12D-909610520BBF Q33361929-4778412A-01A1-4A0C-B40B-F17282768553 Q33718473-1A3D5038-5B59-4352-9BA2-93610CDA2FC7 Q34328750-CFA84C2A-3375-4312-AC13-6EAE599D7C3C Q34441253-773456C2-C6A6-4B4B-8B70-96C95E2DA911 Q35552852-9FB2D767-1775-4F69-8EBB-B99638D96817 Q35562693-32085132-0090-4824-B1C0-AA27CD6E572E Q35768716-5836F748-8AE0-4536-A25D-21F8A8781F39 Q36376753-BED3EB5B-1B4C-45E3-99CF-36193765B342 Q36481790-B44298F7-54C3-4CCC-826B-D1A773278074 Q36509450-6C657C18-D24E-4D75-857B-6EAEB6B4824F Q36578668-B37498A7-42D3-4B18-BFA5-05CDC56E2595 Q36787608-0739C59F-E383-4015-B649-EB66F5DB0003 Q37094730-547D19BA-3348-4525-8212-0576FEEABF01 Q37271260-A607A97F-C26A-4966-A095-14D68A52AE92 Q37289299-723E69ED-B55E-4691-9B5A-08588413DF9C Q37494563-E79F9500-8C43-4261-AE71-1CEC8A0A00D8 Q37636855-8D3DADD3-D04D-446C-91FB-987B9C838EF4 Q37728933-82F200D1-368B-441A-8FC1-E1DD1C345494 Q38319148-FBC41B51-A0D1-4151-8798-B0C5DC79B073 Q38418286-F379C0C7-01EC-4044-8F27-7E1E24770D87 Q39005090-FF24320E-D08F-4484-ABC0-3BCF1C446411 Q39078431-A4B21484-5693-4AF1-B55B-49682F9FA607 Q40048806-DE77C4D7-08F4-47F1-A6EB-6A7977FD9BFC

P2860

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

http://www.wikidata.org/entity/Q24646731

description

1997 nî lūn-bûn

@nan

1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@ast

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@en

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@nl

type

label

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@ast

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@en

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@nl

prefLabel

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@ast

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@en

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@nl

P1433

Q24646731-7C94C519-02B6-4327-97DC-4CD65FCFEB56

P1476

Q24646731-70326B21-45F4-46A7-B983-AA821F90D862

P2093

Q24646731-8DC6CE08-6267-420D-A385-34B427C87E99

Q24646731-A1E1ECCB-AC9F-4EB4-9ECE-0ECA5387CB83

Q24646731-DAD6A4EE-7FE1-417C-AF4E-4256DBFD2736

Q24646731-F4A65839-5BB0-4D53-B8B5-DAFD321358E3

P2860

Q24646731-014E1A34-E2B4-463D-A1B4-3A549ED089C1

Q24646731-0DA6EA73-49D0-44A8-981A-FDD9A363EE5C

Q24646731-12EFBA62-153E-4949-9832-90CD59D27098

Q24646731-19FD749A-0D2B-4BE0-905E-ED5050519B71

Q24646731-1B6C3C50-34C8-4F78-807B-48A808524C68

Q24646731-2AB46544-FD53-4F91-9E54-1EF6ECDE2A8E

Q24646731-374B324B-B25B-4FAF-9513-0E2C0BEC3D7D

Q24646731-44F0D096-77DE-4555-89F9-9DB2EC856BC3

Q24646731-582D827E-7AE8-46D9-89F3-B0211FE437E6

Q24646731-5872841B-3F5D-4C3C-B6AA-D68A9D7B0763

P304

Q24646731-39E10611-816E-4B46-8431-0D48BC3D30E6

P31

Q24646731-04DFE88D-D75E-42CD-BCA8-DAF5D62C8D7A

P356

Q24646731-7B7B2E68-5F32-4AF4-B2D7-31648666B4DF

P407

Q24646731-73304658-D5BD-4B92-B967-068AEB6FEEDA

P433

Q24646731-D628B309-3F53-447E-9BDE-B87DA35430F1

P478

Q24646731-0CCBF090-C048-4C7D-AE2D-2F5C270377CC

P577

Q24646731-2A0676BD-AC0D-444F-8E77-545548AE7409

P5875

Q24646731-49724376-33A0-49E7-B04C-3738C36DD749

P698

Q24646731-F30B2EB0-AC76-417D-A2CE-8C2ACCF043C1

P932

Q24646731-49737658-DC4A-4A03-9999-FBA8E5A57A0B

P356

P1433

Molecular and Cellular Biology

P1476

Suppression of autocrine and p ...... ion of perlecan antisense cDNA

@en

P2093

A Yayon

http://www.w3.org/2001/XMLSchema#string

D Aviezer

http://www.w3.org/2001/XMLSchema#string

D M Noonan

http://www.w3.org/2001/XMLSchema#string

R V Iozzo

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of syndecan, an integral membrane proteoglycan

Abnormal expression of perlecan proteoglycan in metastatic melanomas

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells

Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Control of angiogenesis by heparin and other sulfated polysaccharides.

P304

1938-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.17.4.1938

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

1997-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14097767

http://www.w3.org/2001/XMLSchema#string

P698

9121441

http://www.w3.org/2001/XMLSchema#string

P932

232040

http://www.w3.org/2001/XMLSchema#string